Cantab Pharmaceuticals

Item contains draft licensing agreements, letters of intent and correspondence relating to a research collaboration between the Kennedy Institute and Cantab Pharmaceuticals. The collaboration largely focused on the licensing and exploitation of patent application led by Kennedy Institute Scientist Dr Yuti Chernajovsky. Item also includes collaboration agreement including Marc Feldmann for the study of OX40 in mouse collagen induced arthritis model of rheumatoid arthritis.

1997-1998

1 file (in 2 parts)

This item requires facilitated access. Email library@wellcomecollection.org to request an appointment.